MCID: FML035
MIFTS: 48

Familial Hyperlipidemia malady

Genetic diseases, Rare diseases, Metabolic diseases, Endocrine diseases categories

Aliases & Classifications for Familial Hyperlipidemia

About this section

Aliases & Descriptions for Familial Hyperlipidemia:

Name: Familial Hyperlipidemia 8 10
Familial Hyperlipoproteinemia 8 61
Familial Hyperlipemia 61
 
Hyperlipidemia 61
Hyperlipemia 8


Classifications:



External Ids:

Disease Ontology8 DOID:1168

Summaries for Familial Hyperlipidemia

About this section
MalaCards based summary: Familial Hyperlipidemia, also known as familial hyperlipoproteinemia, is related to hyperchylomicronemia, late-onset and hyperlipidemia, familial combined. An important gene associated with Familial Hyperlipidemia is USF1 (upstream transcription factor 1), and among its related pathways are Binding and Uptake of Ligands by Scavenger Receptors and PPAR signaling pathway. The drugs fish oils and coenzyme q10 and the compounds psyllium and fenofibric acid have been mentioned in the context of this disorder. Affiliated tissues include heart, and related mouse phenotypes are adipose tissue and liver/biliary system.

Related Diseases for Familial Hyperlipidemia

About this section

Diseases in the Familial Hyperlipidemia family:

Hyperlipidemia Type 3

Diseases related to Familial Hyperlipidemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 85)
idRelated DiseaseScoreTop Affiliating Genes
1hyperchylomicronemia, late-onset30.2LPL, APOC2, APOE
2hyperlipidemia, familial combined30.2APOE, APOA1, APOB, HMGCR
3cholestasis30.1LIPC, CETP, LCAT
4hypercholesterolemia, familial29.9HMGCR, PCSK9, CETP, LDLR, APOB
5xanthomatosis29.7APOE, APOB, LDLR, LPL
6nephrotic syndrome29.0HMGCR, LCAT, LPL, LPA, CETP, APOB
7hyperlipidemia type 328.5APOA5, APOA1, APOE, APOB, LIPC, LDLR
8hypertriglyceridemia27.0APOA1, APOE, INS, APOC3, APOA5, APOA2
9cerebral atherosclerosis10.4APOA1
10hepatic lipase deficiency10.4LIPC
11chylomicron retention disease10.4APOB
12lipoprotein glomerulopathy10.4APOE
13hypercholesterolemia, familial, autosomal recessive10.3LDLR, PCSK9
14amyloidosis, familial visceral10.3APOA2, APOA1
15stroke, ischemic10.3COG2, LPA, APOA2
16peripheral vascular disease10.3INS
17norum disease10.2APOA1, APOA2, LCAT
18fish-eye disease10.2APOA1, APOA2, LCAT
19sitosterolemia10.2HMGCR
20hyperlipoproteinemia type iii10.2
21familial lipoprotein lipase deficiency10.2
22hypothyroidism10.2APOB, CETP, LPA
23arcus senilis10.2APOA1, APOB, LCAT
24secondary amyloidosis10.2APOA1, LPA, LCAT
25alagille syndrome10.2LCAT, LPA, APOA1
26macular degeneration, age-related, 110.2APOE, APOB
27hemorrhage, intracerebral10.1APOE, HMGCR
28thrombophilia due to thrombin defect10.1HMGCR, CETP, APOB
29alzheimer disease-210.1CETP, APOE
30lipase deficiency, combined10.1LIPC, LPL
31hypercholesterolemia, due to ligand-defective apo b10.1APOE, APOB, LDLR
32glycogen storage disease10.0
33pyloric stenosis10.0
34lipoprotein lipase deficiency10.0
35hyperlipoproteinemia type iv10.0
36extrahepatic cholestasis10.0
37hyperglobulinemic purpura10.0
38hyperphosphatemia10.0
39shwartzman phenomenon10.0
40lactic acidosis10.0
41myeloma10.0
42purpura10.0
43endotheliitis10.0
44pancreatitis, hereditary10.0APOC2, APOB, LPL
45nicotine dependence, protection against10.0APOA1, APOB, LDLR, LPA
46hyperthyroidism9.9INS, APOA2, LDLR
47acute myocardial infarction9.9APOA1, APOB, LPA, LCAT, HMGCR
48hepatoblastoma9.8APOA1, APOA2, APOB, LDLR, HMGCR
49coronary stenosis9.8APOA1, APOB, LIPC, CETP, LPA
50dementia9.8LPL, LPA, CETP, APOE

Graphical network of the top 20 diseases related to Familial Hyperlipidemia:



Diseases related to familial hyperlipidemia

Symptoms for Familial Hyperlipidemia

About this section

Drugs & Therapeutics for Familial Hyperlipidemia

About this section

Drug clinical trials:

Search ClinicalTrials for Familial Hyperlipidemia

Search NIH Clinical Center for Familial Hyperlipidemia

Inferred drug relations via UMLS61/NDF-RT40:

Genetic Tests for Familial Hyperlipidemia

About this section

Anatomical Context for Familial Hyperlipidemia

About this section

MalaCards organs/tissues related to Familial Hyperlipidemia:

31
Heart

Animal Models for Familial Hyperlipidemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Familial Hyperlipidemia:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053757.9LPL, LDLR, APOC3, APOE, INS
2MP:00053706.8INS, APOE, APOA1, APOB, LDLR, LPL
3MP:00053856.6INS, APOE, APOA1, APOC3, APOB, LDLR
4MP:00053765.8PCSK9, INS, APOE, APOA1, APOC3, APOA5

Publications for Familial Hyperlipidemia

About this section

Articles related to Familial Hyperlipidemia:

(show all 24)
idTitleAuthorsYear
1
Comparison of carotid intima-media thickness in pediatric patients with metabolic syndrome, heterozygous familial hyperlipidemia and normals. (24955251)
2014
2
An infant with milky blood : an unusual but treatable case of familial hyperlipidemia. (24426212)
2013
3
Novel pharmacotherapies of familial hyperlipidemia. (23639874)
2013
4
Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation. (23896536)
2013
5
Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics. (22531366)
2013
6
Diffuse involvement of aorta in patient with familial hyperlipidemia. (22347657)
2011
7
Supravalvular aortic stenosis secondary to severe lipid accumulation in the ascending aorta in a patient with uncontrolled familial hyperlipidemia. (21918328)
2011
8
Antihyperlipidemic agents cause a decrease in von Willebrand factor levels in pediatric patients with familial hyperlipidemia. (21073119)
2010
9
Pregnancy-induced severe gestational hyperlipidemia mimicking familial hyperlipidemia. (17097797)
2008
10
Association between physical activity, adiposity, and lipid abnormalities in children with familial hyperlipidemia. (17301628)
2007
11
Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia]. (15854507)
2005
12
Micro- and macrocirculatory effects of apheresis in patients with familial hyperlipidemia. (12921126)
2003
13
A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. (12032266)
2002
14
Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia]. (9547191)
1997
15
Atypical pyloric stenosis in an infant with familial hyperlipidemia. (8657477)
1996
16
MR imaging of Achilles tendon in patients with familial hyperlipidemia: comparison with plain films, physical examination, and patients with traumatic tendon lesions. (7839978)
1995
17
Adult cardiologists or hyperlipidemia experts have advocated no screening and no treatment for children with familial hyperlipidemia. (8435922)
1993
18
Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese. (2375785)
1990
19
Familial hyperlipidemia in stroke in the young. (3810712)
1986
20
Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. (6655789)
1983
21
Familial hyperlipidemia in coronary atherosclerotic heart disease. (6619068)
1983
22
Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome. (578151)
1977
23
Glycogen storage disease previously reported as familial hyperlipidemia. (5215216)
1965
24
THIN-LAYER CHROMATOGRAPHIC ANALYSIS OF PLASMA PHOSPHOLIPIDS IN ESSENTIAL FAMILIAL HYPERLIPIDEMIA. (14226394)
1964

Variations for Familial Hyperlipidemia

About this section

Expression for genes affiliated with Familial Hyperlipidemia

About this section
Search GEO for disease gene expression data for Familial Hyperlipidemia.

Pathways for genes affiliated with Familial Hyperlipidemia

About this section

Pathways related to Familial Hyperlipidemia according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.0APOA1, APOB, APOE
2
Show member pathways
fatty acid beta-oxidation VI (peroxisome)36
8.9APOA1, APOA5, APOA2, LPL, APOC3
3
Show member pathways
thioredoxin pathway36
8.8APOB, LDLR, APOA1, INS
4
Show member pathways
8.8APOA1, APOA5, HMGCR, APOA2, LPL
5
Show member pathways
Vitamin B12 Metabolism36
8.7INS, APOE, APOA1
6
Show member pathways
8.5LPL, LDLR, INS, HMGCR
7
Show member pathways
7.4APOA1, APOE, APOC3, APOA2, APOC2, APOB
8
Show member pathways
6.8APOC3, APOA2, APOC2, LDLR, LPL, APOA1
96.8APOE, INS, APOB, APOA1, APOC3, APOA2
10
Show member pathways
5.8APOC2, APOB, LIPC, LDLR, CETP, LPA
11
Show member pathways
5.8APOB, CETP, APOC2, LIPC, LDLR, APOA2
12
Show member pathways
4.8APOC3, HMGCR, LCAT, LPL, LPA, CETP

Compounds for genes affiliated with Familial Hyperlipidemia

About this section

Compounds related to Familial Hyperlipidemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 450)
idCompoundScoreTop Affiliating Genes
1psyllium449.1LCAT, CETP, LDLR, HMGCR, APOB
2fenofibric acid44 289.9APOC3, APOA1, HMGCR, LPL, APOB
3colestipol448.9APOB, COG2, HMGCR, APOA1
4mspi448.8APOA1, APOC3, LPA, CETP, LDLR, APOB
5ciprofibrate44 289.6APOA1, APOB, LDLR, LPL, HMGCR
6acipimox44 289.6APOA1, INS, HMGCR, CETP, APOB
7lathosterol44 249.5CETP, LDLR, HMGCR, APOE, APOB
8sele448.4LDLR, APOE, CETP, APOC3, LPL
9dimyristoylphosphatidylcholine448.3LPA, LDLR, APOA2, APOA5, APOA1, APOE
10xbai448.2CETP, APOC3, LDLR, APOE, APOB, LPL
11ezetimibe44 119.0APOA1, INS, APOB, LDLR, CETP, HMGCR
12retinyl palmitate44 249.0APOA1, APOB, APOE, COG2, LPL, LCAT
13sodium dodecylsulfate447.8APOC2, CETP, LIPC, LPA, LPL, APOE
14homocysteine44 248.8LPA, CETP, APOB, APOC2, APOC3, APOA1
15ritonavir44 50 119.7LPL, APOC3, HMGCR, INS, APOE, LDLR
16cholestyramine447.6HMGCR, COG2, LPA, CETP, LDLR, APOB
17alpha tocopherol447.5LCAT, HMGCR, CETP, LDLR, APOB, LPL
18aspirin44 50 28 2410.4COG2, HMGCR, APOE, APOB, LPA, CETP
19fluvastatin44 50 28 1110.3CETP, LDLR, APOB, APOA1, APOE, LPL
20rosiglitazone28 44 50 24 1111.3COG2, INS, LPA, APOC3, APOE, LPL
21niacin44 118.2INS, APOA1, HMGCR, COG2, LPL, LPA
22fibrinogen447.2INS, APOA1, APOC3, APOA2, LIPC, COG2
23probucol44 118.1CETP, LDLR, LIPC, APOB, APOA1, APOE
24carbohydrates447.0CETP, LDLR, LPL, LIPC, APOC3, APOE
25rosuvastatin44 50 28 1110.0COG2, CETP, LDLR, APOB, APOC3, APOA1
26phosphatidylcholine446.9LIPC, APOB, APOA2, APOA1, APOE, LDLR
27palmitate446.8INS, APOE, APOA1, COG2, LCAT, LPL
28intralipid446.8LCAT, LPL, CETP, LIPC, APOB, APOA2
29creatinine446.7INS, APOA1, APOC3, HMGCR, COG2, LPA
30vitamin a44 24 118.7LCAT, LPL, LPA, CETP, LDLR, LIPC
31sterol446.7HMGCR, PCSK9, COG2, LCAT, CETP, LDLR
32glucose446.6APOA5, COG2, APOA2, APOB, APOC3, APOA1
33pravastatin44 50 28 24 1110.5LCAT, LPL, LPA, CETP, LDLR, APOB
34simvastatin44 50 60 28 24 1111.5APOE, HMGCR, COG2, LCAT, LPL, LPA
35phospholipid446.2LPL, COG2, LCAT, CETP, LDLR, LIPC
36lovastatin44 50 60 28 1110.1APOA5, APOC3, APOA1, APOE, APOB, HMGCR
37testosterone44 60 24 119.0CETP, LIPC, APOE, APOA1, APOC3, COG2
38fatty acid446.0LCAT, LPL, LPA, CETP, COG2, LDLR
39serine446.0INS, APOE, APOA1, APOB, APOC2, APOA2
40thyroxine44 246.9APOB, APOA1, APOE, INS, LDLR, HMGCR
41cholesterol ester445.8APOE, APOA1, APOC3, APOA2, HMGCR, COG2
42atorvastatin44 50 28 24 119.8HMGCR, COG2, LCAT, LPL, LPA, CETP
43heparin44 28 24 118.6APOC3, APOE, APOA5, APOA2, LCAT, LPL
44triacylglycerol445.4LCAT, LPL, CETP, LDLR, LIPC, APOB
45estrogen445.3LDLR, COG2, LCAT, LPL, LPA, CETP
46gemfibrozil28 44 117.3HMGCR, COG2, INS, APOE, LPL, LPA
47fenofibrate44 50 117.2HMGCR, COG2, LPL, LPA, CETP, LDLR
48bezafibrate44 28 117.2APOC3, APOA1, APOE, INS, APOA2, APOB
49cholesterol44 28 24 117.3COG2, HMGCR, PCSK9, APOA1, APOC3, APOA2
50lipid444.2APOE, USF1, INS, APOA1, APOC3, APOA5

GO Terms for genes affiliated with Familial Hyperlipidemia

About this section

Cellular components related to Familial Hyperlipidemia according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1spherical high-density lipoprotein particleGO:00343669.6APOC2, APOA1, APOC3, APOA2
2endosome lumenGO:00319049.5INS, APOB
3secretory granule lumenGO:00347749.5APOA1, INS
4extrinsic component of external side of plasma membraneGO:00312329.3PCSK9, APOE
5endocytic vesicle lumenGO:00716829.1APOE, APOB, APOA1
6intermediate-density lipoprotein particleGO:00343639.1APOB, APOC2, APOE, APOC3
7endoplasmic reticulum lumenGO:00057889.0INS, APOA1, APOA2, APOB
8late endosomeGO:00057708.7PCSK9, LDLR, APOE
9low-density lipoprotein particleGO:00343628.7LDLR, APOB, APOC2, APOE, APOA5
10chylomicronGO:00426278.2APOC2, APOE, APOC3, APOA5, APOA2, APOB
11high-density lipoprotein particleGO:00343648.1LCAT, APOA2, CETP, APOA5, APOE, APOA1
12early endosomeGO:00057697.9LDLR, APOB, APOC2, APOA2, APOC3, APOA1
13very-low-density lipoprotein particleGO:00343617.8APOB, LPL, APOA5, APOA1, APOE, APOA2
14extracellular regionGO:00055766.3APOA1, APOA2, APOC3, APOC2, INS, LCAT
15extracellular spaceGO:00056156.1APOC3, INS, LPL, CETP, LIPC, APOB

Biological processes related to Familial Hyperlipidemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 61)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cholesterol importGO:006062110.4APOC3, APOA2
2positive regulation of very-low-density lipoprotein particle remodelingGO:001090210.3APOC2, APOA5
3negative regulation of cholesterol transportGO:003237510.3APOC2, APOA2
4negative regulation of low-density lipoprotein particle clearanceGO:001098910.3APOC3, PCSK9
5negative regulation of lipid metabolic processGO:004583310.2APOC3, APOC2
6negative regulation of lipase activityGO:006019210.2APOA1, APOA2
7negative regulation of very-low-density lipoprotein particle clearanceGO:001091610.2APOC3, APOC2
8triglyceride-rich lipoprotein particle remodelingGO:003437010.2APOA5, APOC2, APOA2
9positive regulation of lipid catabolic processGO:005099610.1APOA2, APOA5
10negative regulation of very-low-density lipoprotein particle remodelingGO:001090310.1APOA2, APOC3, APOA1
11regulation of intestinal cholesterol absorptionGO:003030010.1APOA2, APOA1
12lipoprotein transportGO:004295310.1APOC3, APOC2, APOB
13chylomicron remodelingGO:003437110.0LPL, APOC2
14cholesterol importGO:007050810.0APOA1, LDLR
15protein oxidationGO:001815810.0APOA1, APOA2
16phosphatidylcholine biosynthetic processGO:000665610.0APOA2, APOA1, LCAT
17organ regenerationGO:00311009.9APOA1, APOA5, APOA2
18lipid transportGO:00068699.9APOA5, CETP, LPA
19negative regulation of cytokine secretion involved in immune responseGO:00027409.9APOA2, APOA1
20peptidyl-methionine modificationGO:00182069.9APOA1, APOA2
21triglyceride mobilizationGO:00066429.8APOB, APOC3
22negative regulation of lipid catabolic processGO:00509959.8APOA2, APOC3, INS
23negative regulation of vasodilationGO:00459089.7INS, HMGCR
24cellular lipid metabolic processGO:00442559.6APOA5, APOA2, HMGCR, APOA1
25high-density lipoprotein particle assemblyGO:00343809.5APOE, APOA2, APOA1
26positive regulation of cholesterol esterificationGO:00108739.5APOA1, APOE, APOA2
27regulation of Cdc42 protein signal transductionGO:00324899.5APOC3, APOA1, APOE
28lipoprotein catabolic processGO:00421599.3LDLR, APOB, APOE
29response to drugGO:00424939.3APOC3, LPL, APOC2, APOA2, APOA1
30high-density lipoprotein particle clearanceGO:00343849.3APOE, APOA1, APOA2, APOC2
31cholesterol transportGO:00303019.3APOB, LDLR, CETP, APOA1, LCAT
32chylomicron remnant clearanceGO:00343829.2APOC2, APOE, LIPC, APOC3
33lipoprotein biosynthetic processGO:00421589.1APOA1, APOB, LCAT, APOE
34triglyceride catabolic processGO:00194339.1APOC3, APOA5, LPL, LIPC, APOB
35phospholipid effluxGO:00337009.1APOE, APOA1, APOC3, APOA2, APOC2
36peripheral nervous system axon regenerationGO:00140129.0APOE, APOA1
37low-density lipoprotein particle remodelingGO:00343748.8APOE, APOA2, APOB, LIPC, CETP
38receptor-mediated endocytosisGO:00068988.7APOE, APOB, LDLR, CETP, LPA
39cholesterol effluxGO:00333448.7APOC3, APOB, APOC2, APOA2, APOE, APOA1
40triglyceride homeostasisGO:00703288.6APOA5, APOC2, LIPC, CETP, LPL, APOA1
41triglyceride metabolic processGO:00066418.4APOA5, APOC3, APOE, APOA2, CETP, LPL
42very-low-density lipoprotein particle remodelingGO:00343728.3LCAT, LPL, CETP, LIPC, APOC2, APOE
43high-density lipoprotein particle remodelingGO:00343758.3APOC3, APOA2, LIPC, CETP, APOA1, APOE
44reverse cholesterol transportGO:00436918.1LCAT, APOE, APOA1, APOC3, APOA2, APOC2
45retinoid metabolic processGO:00015237.8LPL, LDLR, APOB, APOC2, APOA2, APOC3
46phototransduction, visible lightGO:00076037.8APOA1, APOE, APOB, LPL, APOC2, APOA2
47cholesterol metabolic processGO:00082037.3APOE, APOA1, APOC3, PCSK9, LCAT, CETP
48cholesterol homeostasisGO:00426326.9APOC3, APOA5, APOA2, APOC2, APOB, LIPC
49lipoprotein metabolic processGO:00421576.5APOE, APOA1, PCSK9, APOC3, APOA5, APOA2
50small molecule metabolic processGO:00442815.7LPA, LPL, LCAT, HMGCR, INS, APOE

Molecular functions related to Familial Hyperlipidemia according to GeneCards Suite gene sharing:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1lipoprotein lipase activator activityGO:006023010.2APOC2, APOA5
2phosphatidylcholine bindingGO:003121010.0APOA5, CETP, APOA2
3high-density lipoprotein particle receptor bindingGO:007065310.0APOA1, APOC3, APOA2
4apolipoprotein receptor bindingGO:003419010.0APOA2, PCSK9, APOA1
5lipase bindingGO:003547310.0APOB, APOA5
6high-density lipoprotein particle bindingGO:00080359.9APOA2, APOA1
7triglyceride bindingGO:00171299.9LPL, CETP
8phospholipid transporter activityGO:00055489.9APOA1, CETP
9lipase inhibitor activityGO:00551029.8APOC2, APOA2, APOA1, APOC3
10cholesterol bindingGO:00154859.7APOA2, APOC3, APOA1, CETP
11low-density lipoprotein particle bindingGO:00301699.6PCSK9, LIPC, LDLR
12very-low-density lipoprotein particle receptor bindingGO:00703269.5APOE, PCSK9
13phospholipase activityGO:00046209.4LPL, LIPC
14lipid transporter activityGO:00053199.4APOE, APOA2, CETP
15phosphatidylcholine-sterol O-acyltransferase activator activityGO:00602289.4APOE, APOA1, APOA2
16apolipoprotein bindingGO:00341859.3LPL, LPA, LIPC, PCSK9
17low-density lipoprotein particle receptor bindingGO:00507509.2PCSK9, APOA5, APOE, APOB
18lipid bindingGO:00082899.0CETP, APOE, APOA5, APOA2, APOC2
19cholesterol transporter activityGO:00171278.9APOA2, APOA1, APOE, APOB, CETP
20phospholipid bindingGO:00055438.6APOC3, APOA1, APOA2, APOA5, APOE, APOB
21protein homodimerization activityGO:00428038.3APOE, HMGCR, APOC2, USF1, APOA2
22heparin bindingGO:00082018.1LIPC, APOB, LPA, APOA5, LPL, APOE
23protein bindingGO:00055155.8APOB, LPL, LCAT, COG2, PCSK9, LDLR

Sources for Familial Hyperlipidemia

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet